Direct cytotoxicity of Lentinula edodes mycelia extract on human hepatocellular carcinoma cell line

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 7, 2012, Pages 1014-1021

  Yukawa, Hiroshi ^a   Ishikawa, Satoru ^a   Kawanishi, Takashi ^a   Tamesada, Makoto ^a   Tomi, Hironori ^a  

^a Kobayashi Pharmaceutical Co   (Japan)

Author keywords

Apoptosis; Caspase; Hepatocellular carcinom; Lentinula edodes mycelia

Indexed keywords

CASPASE 3; CASPASE 8; DNA NUCLEOTIDYLEXOTRANSFERASE; LENTINULA EDODES EXTRACT; POLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER MORPHOLOGY; CELL DEATH; CELL PROLIFERATION; CELL STRAIN HEPG2; CHROMATIN CONDENSATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG CYTOTOXICITY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CARCINOMA; MOUSE; NICK END LABELING; NONHUMAN; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COMPLEX MIXTURES; DNA FRAGMENTATION; HEP G2 CELLS; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED C57BL; MYCELIUM; RATS; RATS, SPRAGUE-DAWLEY; SHIITAKE MUSHROOMS; SKIN;

EID: 84863555224     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b110657     Document Type: Article

References (36)

1. Lavi I, Friesem D, Geresh S, Hadar Y, Schwartz B. An aqueous polysaccharide extract from the edible mushroom Pleurotus ostreatus induces anti-proliferative and pro-apoptotic effects on HT-29 colon cancer cells. Cancer Lett., 244, 61-70 (2006).
2. Lee JC, Lee KY, Son YO, Choi KC, Kim J, Truong TT, Jang YS. Plant-originated glycoprotein, G-120, inhibits the growth of MCF-7 cells and induces their apoptosis. Food Chem. Toxicol., 43, 961-968 (2005).
3. Hsieh TC, Wu P, Park S, Wu JM. Induction of cell cycle changes and modulation of apoptogenic/anti-apoptotic and extracellular signaling regulatory protein expression by water extracts of I'm-Yunity (PSP). BMC Complement. Altern. Med., 6, 30 (2006).
4. Zaidman BZ, Yassin M, Mahajna J, Wasser SP. Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl. Microbiol. Biotechnol., 67, 453-468 (2005).
5. Zheng R, Jie S, Hanchuan D, Moucheng W. Characterization and immunomodulating activities of polysaccharide from Lentinus edodes. Int. Immunopharmacol., 5, 811-820 (2005).
6. Nie X, Shi B, Ding Y, Tao W. Preparation of a chemically sulfated polysaccharide derived from Grifola frondosa and its potential biological activities. Int. J. Biol. Macromol., 39, 228-233 (2006).
7. Zhang M, Chiu LC, Cheung PC, Ooi VE. Growth-inhibitory effects of a beta-glucan from the mycelium of Poria cocos on human breast carcinoma MCF-7 cells: cell-cycle arrest and apoptosis induction. Oncol. Rep., 15, 637-643 (2006).
8. Cui FJ, Li Y, Xu YY, Liu ZQ, Huang DM, Zhang ZC, Tao WY. Induction of apoptosis in SGC-7901 cells by polysaccharide-peptide GFPS1b from the cultured mycelia of Grifola frondosa GF9801. Toxicol. In Vitro, 21, 417-427 (2007).
9. Ukiya M, Akihisa T, Tokuda H, Hirano M, Oshikubo M, Nobukuni Y, Kimura Y, Tai T, Kondo S, Nishino H. Inhibition of tumor-promoting effects by poricoic acids G and H and other lanostane-type triterpenes and cytotoxic activity of poricoic acids A and G from Poria cocos. J. Nat. Prod., 65, 462-465 (2002).
10. Song TY, Hsu SL, Yen GC. Induction of apoptosis in human hepatoma cells by mycelia of Antrodia camphorata in submerged culture. J. Ethnopharmacol., 100, 158-167 (2005).
11. Watanabe A, Kobayashi M, Hayashi S, Kodama D, Isoda K, Kondoh M, Kawase M, Tamesada M, Yagi K. Protection against D-galactosamine-induced acute liver injury by oral administration of extracts from Lentinus edodes mycelia. Biol. Pharm. Bull., 29, 1651-1654 (2006).
12. Sia GM, Candlish JK. Effects of shiitake (Lentinus edodes) extract on human neutrophils and the U937 monocytic cell line. Phytother. Res., 13, 133-137 (1999).
13. Fang N, Li Q, Yu S, Zhang J, He L, Ronis MJ, Badger TM. Inhibition of growth and induction of apoptosis in human cancer cell lines by an ethyl acetate fraction from shiitake mushrooms. J. Altem. Complement Med., 12, 125-132 (2006).
14. Itoh A, Isoda K, Kondoh M, Kawase M, Kobayashi M, Tamesada M, Yagi K. Hepatoprotective effect of syringic acid and vanillic acid on concanavalin α-induced liver injury. Biol. Pharm. Bull., 32, 1215-1219 (2009).
15. Kojima H, Akaki J, Nakajima S, Kamei K, Tamesada M. Structural analysis of glycogen-like polysaccharides having macrophage-activating activity in extracts of Lentinula edodes mycelia. J Nat Med, 64, 16-23 (2010).
16. Itoh A, Isoda K, Kondoh M, Kawase M, Watari A, Kobayashi M, Tamesada M, Yagi K. Hepatoprotective effect of syringic acid and vanillic acid on CCl4-induced liver injury. Biol. Pharm. Bull., 33, 983-987 (2010).
17. Mizoguchi Y, Yamamoto S. Immunotherapy in liver diseases. Rinsyo Menneki, 17, 452-460 (1985).
18. Sugano N, Hibino Y, Choji Y, Maeda H. Anticarcinogenic actions of water-soluble and alcohol-insoluble fractions from culture medium of Lentinus edodes mycelia. Cancer Lett., 17, 109-114 (1982).
19. Tanaka K, Ishikawa S, Matsui Y, Tamesada M, Harashima N, Harada M. Oral ingestion of Lentinula edodes mycelia extract inhibits B16 melanoma growth via mitigation of regulatory T cell-mediated immunosuppression. Cancer Sci., 102, 516-521 (2011).
20. Itamoto T, Nakahara H, Amano H, Kohashi T, Ohdan H, Tashiro H, Asahara T. Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery, 141, 589-597 (2007).
21. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA-Cancer J. Clin., 55, 74-108 (2005).
22. Lim K, Han C, Dai Y, Shen M, Wu T. Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2. Mol. Cancer Ther., 8, 3046-3055 (2009).
23. Osada A, Iwabuchi T, Kishimoto J, Hamazaki TS, Okochi H. Longterm culture of mouse vibrissal dermal papilla cells and de novo hair follicle induction. Tissue Eng., 13, 975-982 (2007).
24. Frankfurt OS, Krishan A. Apoptosis-based drug screening and detection of selective toxicity to cancer cells. Anticancer Drugs, 14, 555-561 (2003).
25. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 81, 505-512 (1995).
26. Inohara N, Koseki T, del Peso L, Hu Y, Yee C, Chen S, Carrio R, Merino J, Liu D, Ni J, Núñez G. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J. Biol. Chem., 274, 14560-14567 (1999).
27. Shimizu S, Narita M, Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature, 399, 483-487 (1999).
28. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature, 397, 441-446 (1999).
29. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science, 281, 1305-1308 (1998).
30. Nishitoh H, Saitoh M, Mochida Y, Takeda K, Nakano H, Rothe M, Miyazono K, Ichijo H. ASK1 is essential for JNK/SAPK activation by TRAF2. Mol. Cell, 2, 389-395 (1998).
31. Cohen GM. Caspases: the executioners of apoptosis. Biochem. J., 326, 1-16 (1997).
32. Mignotte B, Vayssiere JL. Mitochondria and apoptosis. Eur. J. Biochem., 252, 1-15 (1998).
33. Song TY, Hsu SL, Yeh CT, Yen GC. Mycelia from Antrodia camphorata in submerged culture induce apoptosis of human hepatoma HepG2 cells possibly through regulation of Fas pathway. J. Agric. Food Chem., 53, 5559-5564 (2005).
34. Tsagarakis NJ, Drygiannakis I, Batistakis AG, Kolios G, Kouroumalis EA. Octreotide induces caspase activation and apoptosis in human hepatoma HepG2 cells. World J. Gastroenterol., 17, 313-321 (2011).
35. Wieler S, Gagné JP, Vaziri H, Poirier GG, Benchimol S. Poly(ADPribose) polymerase-1 is a positive regulator of the p53-mediated G1 arrest response following ionizing radiation. J. Biol. Chem., 278, 18914-18921 (2003).
36. Bressac B, Galvin KM, Liang TJ, Isselbacher KJ, Wands JR, Ozturk M. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc. Natl. Acad. Sci. U.S.A., 87, 1973-1977 (1990).